• Medipal Holdings sold shares in eight listed securities from May to October 2026, generating a ¥15.49 billion gain.
• The disposals reduced strategic shareholdings under the Corporate Governance Code and its capital-cost and stock-price management initiative disclosed May 13, 2025.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medipal Holdings Corporation published the original content used to generate this news brief on October 23, 2026, and is solely responsible for the information contained therein.